chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm pain began within a few hours of injection. Mild fever, restlessness began 9 or 10 hours after injection ? treated fever with acetominophen 325 mg. Headache began about 14 or 15 hours after injection ? treated with acetominophen 325 mg. Mild stomach upset (without vomiting) about 23 hours after injection (maybe caused by acetominophen on an empty stomach)
fully vax with booster and hx of covid 9/30/21, tested positive 1/11/21
This case was reported by a other health professional via call center representative and described the occurrence of injection site induration in a male patient who received BEXSERO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, unknown after receiving BEXSERO, the patient experienced injection site induration and injection site erythema. On an unknown date, the outcome of the injection site induration and injection site erythema were unknown. It was unknown if the reporter considered the injection site induration and injection site erythema to be related to BEXSERO. Additional details were provided as follows: This case was 1 of the 3 cases belonging to the patients who received the same lot of BEXSERO and had injection site reactions. The age at vaccination of the patient concerned in this case was not reported. The patient's age was between 16 to 18 years old. The healthcare professional reported that the patient had injection site reactions which included a quarter-sized induration and erythema. At the time of the reporting, the patient specifies and lot number were not available. The medical assistant provided the above information to sales representative. She would likely call in early next week to provide specific information about the patient and vaccine lot.
This spontaneous report was received from a healthcare worker refers to an unspecified number of female children patients. On an unspecified date in 2013 ("In the last 6 months" as reported) GARDASIL (lot# unspecified) route and location unspecified has been hurting more patients during administration. Healthcare worker mentioned the patients had been experienced more pain and burning sensations immediately after administration. Healthcare worker also stated this adverse event occurred after a first, second or third dose, whatever doses the patients happened to have received at the time. The patients had sought medical attention via office visit. At the time of report, the patients had recovered from the events on unspecified date in 2013. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a licensed practical nurse (L.P.N.) and refers to multiple unspecified patient of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapy were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot number: M033334, expiry date: 11-AUG-2018, route of administration was not reported. Temperature time excursion was 1 hour > 46 degree of Fahrenheit but < 77 degree of Fahrenheit , and 3 hours between 32 degree of Fahrenheit  and 36 degree of Fahrenheit. There was no previous temperature excursion. Data logger was involved. No adverse event was reported. This is one of several reports from the same reporter. Additional information has been requested.; Sender's Comments: US--009507513-1702USA007041: US--009507513-1702USA007042: US--009507513-1702USA007040:
I administer Flu Vaccine first and then HPV. Patient was very nervous before vaccines. Right after administration she fainted. She was sitting on exam table and mom was next to her. When she fainted, she had some movements they look like a seizure. I went and got a doctor and when we got back, she was feeling better. I did two sets of vitals and after 15 min her vitals were in normal range, and she was ok to leave.
flu lke sz, muscle ache (large muscle groups);joint pain (legs, arms, hips, & back);
Stiffness in hands and fingers.  Swollen painful joint that pops in right thumb.
At 12:50 pm, patient began to experience visual changes.  VS:  186/76-97% oximeter-Hr=57-59.  Patient mentioned that she had not yet had lunch.  She ate fruit snack and crackers during recovery period.  Continued to monitor vital signs for 30 minutes and blood pressure continued to be elevated.  Her son is a EMT and asked me to contact him.  He mentioned that his mother has a history of double vision.  He asked me to assist her to the mobile transit and ask the driver to assist her into the house to lay down.  He or his wife will be dispatched to home to monitor her in next 15 minutes or so.
Tinnitis, began the day after the vaccine and has not abated.  High-pitched ringing in the ears.
Within 5 days of MMR vaccine, patient had "red bumps" everywhere. Then noticed lumps behind ears on back of neck (lasted 2 1/2 weeks).  Joint pain hands, knees 2 weeks after vaccine.  Never saw her MD - called X 3.  Private MD dismissed patient.  No treatment except Advil for joint pain for a few days.
Much later developed congestive heart failure.  Put on lasix and oxygen for low oxygen levels.
Fever, sore throat, swollen lymph nodes in throat, clavicle, armpits and breasts, fatigue, chest tightness, some shortness of breath, rapid heart rate upon moving
Itchiness; Reddish color; A spontaneous report was received from a consumer concerning a 75-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events reddish color/vaccination site erythema and itchiness/pruritus.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 1 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 013M20A)via unknown route for prophylaxis of COVID-19 infection.  On 8 Feb 2021, the patient developed reddish color and itchiness.No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown   The outcome of events- reddish color and  itchiness -was unknown.
sore arm; headache; lethargy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MOD21-157337 (Moderna).  A 50 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 21Apr2021 (Lot number: EW0171) at the age of 49 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single; lot: EW0150, expiration: unknown, ROA: Intramuscular), administration date: 31Mar2021, when the patient was 49 years old, for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "sore arm"; HEADACHE (non-serious) with onset 2021, outcome "recovered" (2021), described as "headache"; LETHARGY (non-serious) with onset 2021, outcome "unknown", described as "lethargy". Therapeutic measures were taken as a result of headache.  Additional information: The patient was treated with Tylenol for headache. She was not immunocompromised. She was told by her doctor not to worry about the dose she received.  No follow-up attempts are possible. No further information is expected.
tongue numbness/tingling, rapid heart rate, electrical or nerve zap down both arms beginning from shoulders down to fingertips that happened simultaneously (one occurence), slight swelling and tingling sensation of lips.
Client received booster vaccine at 4 months instead of 6 months from last dose.  Client voiced that she realized she and her husband  came too early for vaccine once they got home. Client reports she is feeling fine and not having any problems. Client was given "What to Expect After Covid Vaccine" and told to follow recommendations on form, client voiced understanding.
Full body rash; Full body rash and itchy; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 08:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to food, medications, or other products. Concomitant medications included atorvastatin calcium (ATORVASTIN) and diltiazem (MANUFACTURER UNKNOWN) both for an unknown indications, from unspecified dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 22:30, the patient experienced full body rash and itchy. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. No therapeutic measures was taken as a result of the events. The clinical outcome of the events full body rash and itchy was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
inadvertently given a dose of expired Havrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 2-year-old female patient who received HAV (Havrix) (batch number T57F3, expiry date 16-FEB-2023) for prophylaxis.   On 31-MAY-2023, the patient received Havrix. On 31-MAY-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: inadvertently given a dose of expired Havrix). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 12-JUN-2023 The reporter reported that a patient was inadvertently given a dose of expired Havrix vaccine which led to expired vaccine used.  The reporter consented to follow up.
Spreading rash starting at the stomach. Moved down the legs and up around breasts and stops at armpits. Not itchy or painful, just red bumps and blotches.
Pt experienced "uncontrolled" diarrhea and vomiting for about 6-8 hours starting this morning around 6am. Pt states he drank Gatorade and started feeling better. He did not see a Dr for this issue to resolve.
Woke up 5/21/13, felt achy, had low grade temp < 100 degrees F, took TYLENOL that evening and felt better by the next day. Also, sore red area above injection site measures 75 mm x 40 mm today - oval shaped.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 77-year-old female patient who received SHINGRIX (batch number 5544H, expiry date 15th May 2021) for prophylaxis. On 19th December 2018, the patient received the 1st dose of SHINGRIX (intramuscular). In December 2018, less than a week after receiving SHINGRIX, the patient experienced injection site erythema, injection site lump, injection site induration and injection site warmth. On an unknown date, the outcome of the injection site erythema, injection site lump, injection site induration and injection site warmth were not recovered/not resolved. It was unknown if the reporter considered the injection site erythema, injection site lump, injection site induration and injection site warmth to be related to SHINGRIX. Additional details were provided as follows: On the day of reporting, the patient went to the pharmacy with injection site redness, injection site hard lump and injection site warm to touch.
Within 4 hours of administration of Fluzone vaccine, pt had temperature of 103 degrees and body aches, weak and sore throat.  All symptoms persisted for more than 24 hours.
6-7 hours after 2nd injection neuropathy much more severe - trouble walking and had to hold husbands hand to walk dog; trouble buttoning shirts. This continued for several days. Unsteady into June. I have adjusted, walking ok and buttoning, but not where I was pre-2nd vaccine. Neuropathy above ankles
flu like symptoms; aches and pains; fatigue; discomfort; injection arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (aches and pains), FATIGUE (fatigue), DISCOMFORT (discomfort) and INJECTION SITE PAIN (injection arm hurt) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included TAMSULOSIN, LOSARTAN, AMLODIPINE and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN (aches and pains), FATIGUE (fatigue), DISCOMFORT (discomfort) and INJECTION SITE PAIN (injection arm hurt). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). The patient was treated with ACETAMINOPHEN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 09-Feb-2021, INJECTION SITE PAIN (injection arm hurt) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (aches and pains), FATIGUE (fatigue) and DISCOMFORT (discomfort) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Action taken with mRNA-1273 in response to the events was unknown.  On 9 Feb 2021 the outcome of events, injection arm hurt was resolved. The outcome of events, flu-like symptoms, aches and pains, fatigue, discomfort was unknown.
This spontaneous report was received from a nurse via a company representative refers to a patient of unknown age and gender. On unknown date the patient was vaccinated with PNEUMOVAX23 (dose, Lot# and route were not reported). On unknown date the patient's left arm became swollen from the shoulder to the elbow after receiving PNENUMOVAX23. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
vaccinated with the Pfizer 2 vaccines; prescribed the Paxlovid; vaccinated with the Pfizer 2 vaccines; prescribed the Paxlovid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "vaccinated with the Pfizer 2 vaccines; prescribed the Paxlovid". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient vaccinated with the Pfizer 2 vaccines. The patient had not had a booster and was sick enough that the doctor prescribed the Paxlovid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Was found on the floor, snoring with foam forming out of his mouth. Was sent to the emergency room suffered a heart attack, passed away June 21, 2021.
Patient got home. Started to experience chills. The chills worsened to shuddering & felt like extremities drew in to body. Then felt nauseous. It subsided - so patient fell asleep and woke feeling like "drunk" - staggering & off balance. All symptoms subsided 24 hrs after vaccine. Physician seen day after vaccine 9:30am 10/12/12.
shorth of breath; feeling woozy; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shorth of breath) and DIZZINESS (feeling woozy) in an 86-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21a) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DYSPNOEA (shorth of breath) and DIZZINESS (feeling woozy). At the time of the report, DYSPNOEA (shorth of breath) and DIZZINESS (feeling woozy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.
Patient mistakenly admistered 2 .5cc doses of Anthrax Vaccine (MANUFACTURED BY BIOPORT) in one day.
Shots given Tuesday 11-29-05. Mom called 12-1-05 leg large amount redness and swelling - limping. Tx Motrin, cool soaks, observe. Expect 3-5 days to resolve.
Had the first shot August 2019 without ill effects, this was the follow-up vaccination. I started diarrhea the following evening through the night and most of the day. Next day diarrhea got a little less violent, but Headache and pain in lower back, buttock into the upper legs started. This was not like normal back pain but more like nerves hurting all over the lower body. Had to take Tylenol 500 mg every 4 hours and tried Gabapentin 300mg  at night from Saturday to Sunday and Sunday to Monday. Diarrhea got bad again on Saturday. I finally got better yesterday morning (3/10/2020) and did not require pain medication any longer.
This spontaneous report was received from a other health professional refers to an unspecified patients of unknown age and gender. On 02-AUG-2014, doses of RECOMBIVAX HB were exposed to an unsupported temperature excursion of -1C for "6 to 16 hours". On an unspecified date since 020-AUG-2014, RECOMBIVAX HB (lot # J012567; expiration date; 30-JAN-2016) (dose and route were not reported) were administered to unspecified patients. No adverse effect has been observed or reported. This is one of several reports received from the same reporter.  Follow up has been received from the pharmacist on 20-OCT-2014 concerning a patient of unknown age and gender. The reporter provided another RECOMBIVAX HB lot number J012520, expiration date: 30-JAN-2016 that was improperly stored and would have been included in the original report. Additional information has been requested.
On 10/24 the day following the shot in my left arm and 12 days following the bee sting in my right arm, the area of my bee sting started to itch again and got very red.  Additionally, my thighs started to itch.  By the evening of 10/24, the red area on my arm by my bee sting grew to about the length of my pinky and about half as wide.  It was pulsing dark red/light red with my heartbeat and I had broken out in a rash of small bumps on my thighs.  I treated the arm area with steroid cream and took oral benadryl before bed. I went to see my dermatologist the next morning 10/25 and he believed that my arm was infected, and as I thought, having the flu shot prompted a immune response and major histamine response due to the underlying infection of which I was unaware at the time I had the shot, given that the bee sting redness and swelling had apparently resolved days before the shot. He prescribed a 14 day regimen of Cephalexin which I am still taking and we agreed that I would continue steroid cream twice a day and take Benadryl at night given that I do not tolerate well most other antihistamines. The arm redness and swelling as well as the rash, which had spread to include the area between my waist and knees, worsened for about two days before gradually improving. I had a follow up appointment with Dr. on Friday, Nov 1 by which time the arm was mostly better and the rash had resolved. By today, Nov 3, other than slight discoloration in the area of the bee sting, all has resolved.
Patient noiced pain and swelling at the injection site about 28 hours after the injection when he removed the Band-Aid.  Site on posterior aspect of the deltoid appears reddened and indurated to approximately the size of a lemon.  Area feels warm to touch, but patient has no fever.
Pt reports to treatment area with localized nodule post vaccination at site of injection. Cold compress was applied to site.  VS taken at 10:40am BP 140/72 HR: 51 RR: 17 O2: 95% room air. Swelling observed to have decreased. Pt escorted to car at 11:04am. Pt denies any other symptoms.
Patient was administered the first dose of Moderna vaccine.  Patient tolerated injection well.  At the time of charting, writer noted that patient is 1 7 years, 5 months of age.  This is outside of Moderna's guideline of administration age being 18 & older.  Patient was informed. Education was completed on signs & symptoms of adverse effects to monitor for & instructed to contact Provider if needed.  Patient relayed understanding.   Writer telephoned patient's mom to relay issue. Education was completed on signs & symptoms of adverse effects to monitor for & instructed to contact Provider if needed.  Patient's mom relayed understanding.  No further concerns from patient or his mother at the time of this reporting.
She got her vaccines, later that day she began to feel tired, achy and for 2 days she had mild symptoms of maybe of the flu.  This is not unusual for her, and she normally gets a reaction after her flu vaccines.  She was then back to herself, normal routine, and then she noticed for several days that she did not have any problems with her A-fib which she normally feels on a regular basis, and not unsual for her to feel it every day, but can go 3-4 days to not feel it.  It is not unusual for her to wake up in the middle of the night with the feeling, and seems to happen when it happens.  The thing that is unusual is that she has now not felt it since the vaccine.  Shen then began to look for the reaction, but has not not had any reaction and wonders if the vaccines together have caused the symptoms to have gone away.  She has read that the RSV vaccine can cause A-fib, but since she already had it and for some reason she is having a period where she has not noticed it.    She went to her doctor and mentioned it to him that she was not having any A-fib reactions since the vaccine, and told her it was a coincidence.
Patient came back into office after receiving first dose of Moderna Covid vaccine stating he had bumps  and numbness to his right upper lip.  Patient stated this started about fifteen minutes after receiving the vaccine.   No other cause identified.  Patient given 50mg of Benedryl IM in office.   Pt instructed to go home and rest and report to ER if getting worse.
Pt states had vaccinations on 10/29/08. Pneumonia and Flu vaccine on the Right arm and Td on the left arm. On 11/04/08 in the afternoon pt states left arm started itching.  That evening pt noticed that left arm was red, swollen, warm to touch, hurting and with a rach.  On 11/05/08 pt calls the clinic with above complaints.  Advised pt to come to the clinic for further evaluations.  On evaluation it was found that arm was red, swollen (area of 6x3 inches with a 3mm elevation), warm to touch, itching and painful.  Small milia-like shape pumps were also noticed.  Pt was advised to place cold compresses on the arm, take benadryl for itching and tylenol for the pain.  Also advised pt that if symptoms got worst to go to ER.
patient's mother noticed rash all over body on 10/19/2019, went to ER , was given oral prednisone  daily for 5 days and zyrtec daily as needed, followed up in clinic on 10/22/2019, rash was improving
PC from pts mom on morning of 3DEC91 stating that pt broke out in hives on face & body on night of 2DEC91; MD told mom was probably immun reaction & it should go away by AM; pt still had hives in AM; mom instructed to take pt to MD;
TMcontacted regarding her COVID results. TM reports ongoing diarrhea and HA and is not cleared to RTW at this time. TM informd she had to be without diarrhea for 24 hours to be cleared for work. TM provided and employee injury report to complete for ongoing symptoms